Phase II Study of Pulse 5-Fluoro-2′-Deoxyuridine and Leucovorin in Advanced Colorectal Cancer Patients Previously Treated with Chemotherapy

Phase Ii Study ◽

Previously Treated ◽

5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group

Annals of Oncology ◽

10.1023/a:1008342928408 ◽

2000 ◽

Vol 11 (8) ◽

pp. 1045-1052 ◽

Cited By ~ 29

Author(s):

E. Maiello ◽

V. Gebbia ◽

F. Giuliani ◽

G. Paoletti ◽

N. Gebbia ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Southern Italy ◽

Phase Ii Study ◽

Oncology Group ◽

REVERCE: Randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for metastatic colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, and irinotecan—Biomarker analysis.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.3510 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 3510-3510 ◽

Cited By ~ 3

Author(s):

Yasushi Tsuji ◽

Kohei Shitara ◽

Takeharu Yamanaka ◽

Tadamichi Denda ◽

Katsunori Shinozaki ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Biomarker Analysis ◽

Reverse Sequence ◽

Previously Treated ◽

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-006-0302-x ◽

2006 ◽

Vol 59 (5) ◽

pp. 613-620 ◽

Cited By ~ 14

Author(s):

Daniele Santini ◽

Bruno Vincenzi ◽

Gaia Schiavon ◽

Marisa Di Seri ◽

Vladimir Virzí ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Colorectal Cancer Patients ◽

Line Chemotherapy

A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6603095 ◽

2006 ◽

Vol 94 (9) ◽

pp. 1287-1292 ◽

Cited By ~ 32

Author(s):

M Mabro ◽

◽

P Artru ◽

T André ◽

M Flesch ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Oxaliplatin with Weekly Bolus 5-Fluorouracil and Leucovorin in Pretreated Advanced Colorectal Cancer Patients: A Phase II Study

Chemotherapy ◽

10.1159/000071144 ◽

2003 ◽

Vol 49 (4) ◽

pp. 194-199 ◽

Cited By ~ 11

Author(s):

Tsai-Shen Yang ◽

Jinn-Shium Chen ◽

Reiping Tang ◽

Jy-Ming Chiang ◽

Pau-Shiu Hsieh ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Weekly Bolus ◽

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6601382 ◽

2003 ◽

Vol 89 (10) ◽

pp. 1870-1875 ◽

Cited By ~ 17

Author(s):

C Garufi ◽

E Bria ◽

B Vanni ◽

A M R Zappalà ◽

I Sperduti ◽

...

Keyword(s):

Colorectal Cancer ◽

Folinic Acid ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

British Journal of Cancer ◽

10.1038/sj.bjc.6604121 ◽

2007 ◽

Vol 98 (1) ◽

pp. 71-76 ◽

Cited By ~ 28

Author(s):

S Cascinu ◽

R Berardi ◽

S Salvagni ◽

G D Beretta ◽

V Catalano ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Multicentre Phase ◽

Colorectal Cancer Patients ◽

First Line Treatment

REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients

Annals of Oncology ◽

10.1093/annonc/mdy526 ◽

2019 ◽

Vol 30 (2) ◽

pp. 259-265 ◽

Cited By ~ 12

Author(s):

K. Shitara ◽

T. Yamanaka ◽

T. Denda ◽

Y. Tsuji ◽

K. Shinozaki ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Reverse Sequence ◽

Previously Treated ◽

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

International Journal of Clinical Oncology ◽

10.1007/s10147-019-01414-0 ◽

2019 ◽

Vol 24 (7) ◽

pp. 836-841

Author(s):

Hiroaki Tanioka ◽

Michitaka Honda ◽

Chihiro Tanaka ◽

Yoshitaka Morita ◽

Keiichiro Ishibashi ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Efficacy And Safety ◽

Previously Treated ◽

A Phase II Study of Advanced Colorectal Cancer Patients Treated with Combination 5-Fluorouracil Plus Leucovorin and Subcutaneous Interleukin-2 Plus Alpha Interferon

Journal of Chemotherapy ◽

10.1080/1120009x.1994.11741163 ◽

1994 ◽

Vol 6 (4) ◽

pp. 265-271 ◽

Cited By ~ 2

Author(s):

R. Ridolfi ◽

R. Maltoni ◽

A. Riccobon ◽

E. Flamini ◽

R. Fedriga ◽

...

Keyword(s):

Colorectal Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Alpha Interferon ◽